Delivery Order 75N95019D00037-75N95019F00089
Award Date 9/25/19
Potential Completion Date 5/23/22
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Plainsboro Township, NJ 08536, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The one year, $0.00 potential value task order was awarded by the National Institute on Drug Abuse within the Department of Health and Human Services to support the Center's work developing medications. Performance will take place in Plainsboro Township, New Jersey by Xenobiotic's Biotesting Division. No set aside...
- This task order was awarded under the Analytical Services Center for Medications Development Program indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute on Drug Abuse to Xenobiotic Laboratories Inc.'s Biotesting Division. The $0 task order provides administrative support services for the Analytical Services Center for Medications Development Program, which aims to develop new medications for substance use disorders. Performance will take...
- Xenobiotic Laboratories Inc. Biotesting Division was awarded a $71,740 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to assess the cytochrome P450 (CYP450) enzyme induction potential of two test articles. Performance will take place in Plainsboro Township, New Jersey from August 2023 through March 2024. The award is in response to a solicitation requesting evaluation of the test...
- This is a firm fixed price contract awarded by the National Institute on Drug Abuse (NIDA), an agency of the U.S. Department of Health and Human Services, to Xenotech LLC, doing business as Sekisui-Xenotech, for in vitro metabolism and metabolite quantification services. The period of performance is from July 6, 2015 to July 5, 2020, with a ceiling value of $1,391,921.30. This contract is not set aside for any specific business category. Xenotech, a small disadvantaged business, specializes in...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $109,392.00 contract is for compound testing services, including plasma protein binding studies, PXR and AhR activation studies, and CYP inhibition assays on various small molecule compounds. This work supports NIDA's mission to seek fundamental...
- This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $100,000 firm fixed price delivery order to National Medical Services, Inc., doing business as NMS Labs, against its indefinite-delivery/indefinite-quantity contract number 75N95020D00002. This order, with a period of performance through December 2023, will provide work as described in Attachment 1 of the award notice for an NIMH Task Order and in the proposal submitted by NMS...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a $401,178.36 firm fixed-price delivery order to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for receptor profiling and predictive toxicology services to support NIDA's research initiatives. This task order was issued under a larger $5 million IDIQ contract from NIDA for receptor binding services, which includes...
- This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to National Medical Services, Inc. (NMS Labs), a leading provider of clinical and forensic toxicology services. The $69,355.33 firm-fixed-price contract is for neurobiobank tissue toxicology testing services to support NIDA's substance use disorder research programs. This order was issued under an existing $1.5 million indefinite...
- This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...